Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially ...

Aging research has experienced substantial advancements in the past decade, particularly in understanding the interrelation ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential for other cancers as well. Scientists led by ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Scientists who rely on federal grants for vital research have been left 'panicking' due to the President's threats over funding cuts.

U.S. Rep. Don Beyer of Virginia led 89 of his colleagues in decrying attacks on the NIH that endanger vitally important medical research.

TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...